(Q38128069)

29 August 2017

Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases (English)

1 reference

29 August 2017

0 references

1

1 reference

29 August 2017

3

1 reference

29 August 2017

4

1 reference

29 August 2017

6

1 reference

29 August 2017

Diana Rafael

2

1 reference

PubMed ID

23932923

29 August 2017

Alejandro Sosnik

series ordinal

5

1 reference

PubMed ID

23932923

29 August 2017

language of work or name

English

0 references

publication date

7 August 2013

1 reference

Advanced Drug Delivery Reviews

29 August 2017

1 reference

29 August 2017

65

1 reference

29 August 2017

13-14

1 reference

29 August 2017

1816-1827

1 reference

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

29 August 2017

1 reference

12 December 2020

Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties

1 reference

12 December 2020

Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration.

1 reference

12 December 2020

Formulation strategy and use of excipients in pulmonary drug delivery

1 reference

12 December 2020

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

1 reference

12 December 2020

Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization

1 reference

12 December 2020

Dry powder inhaler formulation.

1 reference

12 December 2020

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

1 reference

12 December 2020

Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.

1 reference

12 December 2020

History of aerosol therapy: liquid nebulization to MDIs to DPIs

1 reference

12 December 2020

Penicillin inhalation in pulmonary disease

1 reference

12 December 2020

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

1 reference

12 December 2020

Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications

1 reference

12 December 2020

Cyclodextrin-based pharmaceutics: past, present and future

1 reference

12 December 2020

Delivery of liposomes in dry powder form: aerodynamic dispersion properties

1 reference

12 December 2020

Antitubercular inhaled therapy: opportunities, progress and challenges

1 reference

12 December 2020

One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis

1 reference

12 December 2020

Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization

1 reference

12 December 2020

Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.

1 reference

12 December 2020

Pneumonia in the intensive care unit

1 reference

12 December 2020

Murine airway histology and intracellular uptake of inhaled amorphous itraconazole

1 reference

12 December 2020

Emerging nanopharmaceuticals

1 reference

12 December 2020

Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative

1 reference

12 December 2020

Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

1 reference

12 December 2020

Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.

1 reference

12 December 2020

Inhalation therapy: an historical review.

1 reference

12 December 2020

Influence of particle size on regional lung deposition--what evidence is there?

1 reference

12 December 2020

Dry powder inhaler device influence on carrier particle performance

1 reference

12 December 2020

Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages

1 reference

12 December 2020

Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice

1 reference

12 December 2020

Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment

1 reference

12 December 2020

Nanomedicine in pulmonary delivery

1 reference

12 December 2020

Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.

1 reference

12 December 2020

Nanoparticle formulations in pulmonary drug delivery

1 reference

12 December 2020

Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes

1 reference

12 December 2020

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

1 reference

12 December 2020

The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies

1 reference

12 December 2020

Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.

1 reference

12 December 2020

In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis

1 reference

12 December 2020

Nanodelivery in airway diseases: challenges and therapeutic applications

1 reference

12 December 2020

Pure insulin nanoparticle agglomerates for pulmonary delivery

1 reference

12 December 2020

Steroid Aerosols in Asthma: An Assessment of Betamethasone Valerate and a 12-month Study of Patients on Maintenance Treatment

1 reference

12 December 2020

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

1 reference

12 December 2020

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery

1 reference

12 December 2020

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

1 reference

12 December 2020

High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.

1 reference

12 December 2020

Ribavirin small-particle-aerosol treatment of influenza B virus infection

1 reference

12 December 2020

Nanomedicine(s) under the microscope

1 reference

12 December 2020

A history of nebulization

1 reference

12 December 2020

Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation

1 reference

12 December 2020

Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains

1 reference

12 December 2020

Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis

1 reference

12 December 2020

Single dose and multiple dose studies of itraconazole nanoparticles.

1 reference

12 December 2020

New respiratory viral infections

1 reference

12 December 2020

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.

1 reference

12 December 2020

Preparation and use of liposomes in the treatment of microbial infections

1 reference

12 December 2020

The failure of exubera: are we beating a dead horse?

1 reference

12 December 2020

Inhaled antimicrobial therapy: from cystic fibrosis to the flu.

1 reference

12 December 2020

Development of nanoparticles for antimicrobial drug delivery

1 reference

12 December 2020

Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model

1 reference

12 December 2020

Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection

1 reference

12 December 2020

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

1 reference

12 December 2020

Amphotericin B: side effects and toxicity

1 reference

12 December 2020

Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages

1 reference

12 December 2020

Killer respiratory tract infections: time to turn the tide

1 reference

12 December 2020

Nanocarriers for pulmonary administration of peptides and therapeutic proteins

1 reference

12 December 2020

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

1 reference

12 December 2020

Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.

1 reference

12 December 2020

Liposomes as drug delivery systems for the treatment of TB.

1 reference

12 December 2020

Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro

1 reference

12 December 2020

Biodegradable polymeric nanocarriers for pulmonary drug delivery

1 reference

12 December 2020

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

1 reference

12 December 2020

Penicillin nebulization in bronchopulmonary disease; a preliminary report

1 reference

12 December 2020

Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model

1 reference

12 December 2020

Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors

1 reference

12 December 2020

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

1 reference

12 December 2020

Liposomes for drug delivery to the lungs by nebulization.

1 reference

12 December 2020

Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection

1 reference

12 December 2020

Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis

1 reference

12 December 2020

Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection

1 reference

12 December 2020

Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters

1 reference

12 December 2020

Inhaled drug delivery for tuberculosis therapy

1 reference

12 December 2020

International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.

1 reference

12 December 2020

Aerosol drug delivery: developments in device design and clinical use.

1 reference

12 December 2020

Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection

1 reference

12 December 2020

Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation

1 reference

12 December 2020

In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols

1 reference

12 December 2020

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

1 reference

12 December 2020

Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

1 reference

12 December 2020

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

1 reference

12 December 2020

Future of nanomedicine: obstacles and remedies

1 reference

12 December 2020

Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis

1 reference

12 December 2020

Inhaled penicillin in bronchial infections

1 reference

12 December 2020

Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice

1 reference

12 December 2020

Toxicological evaluation of lactose and chitosan delivered by inhalation

1 reference

12 December 2020

Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.

1 reference

12 December 2020

New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

1 reference

12 December 2020

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

1 reference

12 December 2020

Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect.

1 reference

12 December 2020

Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa

1 reference

12 December 2020

Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections

1 reference

12 December 2020

Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

1 reference

12 December 2020

Particulate and vesicular drug carriers in the management of tuberculosis.

1 reference

12 December 2020

The activity of low-clearance liposomal amikacin in experimental murine tuberculosis

1 reference

12 December 2020

Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats

1 reference

12 December 2020

Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections

1 reference

12 December 2020

Science and regulation. FDA's approach to regulation of products of nanotechnology

1 reference

12 December 2020

Formulation of rifampicin-cyclodextrin complexes for lung nebulization

1 reference

12 December 2020

Liposome-based drug delivery to alveolar macrophages

1 reference

12 December 2020

Viral respiratory tract infections and asthma: the course ahead

1 reference

12 December 2020

Chitosan-coated liposomes for delivery to lungs by nebulisation.

1 reference

12 December 2020

Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus

1 reference

12 December 2020

Aerosol vaccines for tuberculosis: a fine line between protection and pathology

1 reference

12 December 2020

Biomedical detection via macro- and nano-sensors fabricated with metallic and semiconducting oxides

1 reference

12 December 2020

10.1016/J.ADDR.2013.07.020

Identifiers

DOI

1 reference

29 August 2017

0 references

1 reference

PubMed ID

23932923